Safety and Tolerability of Oral LCL161 in Japanese Adult Patients With Advanced Solid Tumors
Clinical trial NCT01968915 · COMPLETED
Trial details
- NCT number
- NCT01968915
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2015-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.